At Bluestone Pharma®, we are dedicated to improving health with a strong focus on the human oral microbiome. Our mission is to develop and manufacture innovative and clinical efficacious probiotic formulas using proprietary technology and strong clinical evidence. This ensures that our partners gain a competitive edge in the probiotic market, driving their success. Bactoblis®, our flagship probiotic, is the most clinically tested formula for recurrent respiratory infections in children and teenagers, backed by over 30 clinical studies. Since our founding in 2013, we have expanded into 25 countries, with healthcare professionals prescribing over 200 million doses of our products globally.
| Website | https://www.bluestone-pharma.com |
| Revenue | $9 million |
| Employees | 9 (4 on RocketReach) |
| Founded | 2013 |
| Technologies |
JavaScript
,
HTML
,
PHP
+4 more
(view full list)
|
| Industry | Biotechnology Research, Manufacturing General, Manufacturing |
| Keywords | Probiotics, Oral Microbiome, Gut Health, Human Microbiome, Digestive Health, Pharmaceutical, Biotechnology, Health Supplements, Clinical Research, Drug Development, Innovative Formulas, Proprietary Technology, Microbiome Therapeutics, Pharmaceutical Manufacturing, Scientific Research, Health And Wellness, Microbiome Science, Clinical Trials, Gastrointestinal Health, Probiotic Supplements |
| Competitors | Roche, Novartis, Merck AH, AbbVie, Pfizer, Sanofi, GSK, Bristol Myers Squibb, Amgen, MedImmune +37 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Bluestone Pharma employee's phone or email?
The Bluestone Pharma annual revenue was $9 million in 2026.
Steven Dijkhuizen is the COO of Bluestone Pharma.
4 people are employed at Bluestone Pharma.
The NAICS codes for Bluestone Pharma are [32541, 3254, 325, 32].
The SIC codes for Bluestone Pharma are [283, 28].